Schonfeld Strategic Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-592,847
| Closed | -$60.2M | – | 2358 |
|
|
2025
Q4 | $60.2M | Buy |
+592,847
| New | +$47.6M | 0.27% | 43 |
|
|
2025
Q3 | – | Sell |
-319,311
| Closed | -$17M | – | 2311 |
|
|
2025
Q2 | $17M | Buy |
319,311
+299,041
| +1,475% | +$15.2M | 0.12% | 202 |
|
|
2025
Q1 | $877K | Sell |
20,270
-1,438
| -7% | -$72.8K | 0.01% | 1341 |
|
|
2024
Q4 | $1.22M | Buy |
21,708
+17,231
| +385% | +$1.07M | 0.01% | 1032 |
|
|
2024
Q3 | $305K | Buy |
+4,477
| New | +$253K | ﹤0.01% | 1646 |
|
|
2024
Q1 | – | Sell |
-21,507
| Closed | -$1.59M | – | 2157 |
|
|
2023
Q4 | $1.59M | Buy |
21,507
+17,967
| +508% | +$1.18M | 0.01% | 879 |
|
|
2023
Q3 | $241K | Sell |
3,540
-5,110
| -59% | -$434K | ﹤0.01% | 1372 |
|
|
2023
Q2 | $812K | Buy |
+8,650
| New | +$675K | 0.01% | 1050 |
|
|
2023
Q1 | – | Sell |
-9,740
| Closed | -$482K | – | 2245 |
|
|
2022
Q4 | $482K | Sell |
9,740
-4,773
| -33% | -$195K | ﹤0.01% | 1547 |
|
|
2022
Q3 | $471K | Buy |
+14,513
| New | +$598K | ﹤0.01% | 1797 |
|
|
2021
Q1 | – | Sell |
-11,812
| Closed | -$1.56M | – | 1886 |
|
|
2020
Q4 | $1.56M | Buy |
+11,812
| New | +$1.43M | 0.02% | 666 |
|
|
2020
Q3 | – | Sell |
-10,032
| Closed | -$873K | – | 1440 |
|
|
2020
Q2 | $873K | Sell |
10,032
-18,525
| -65% | -$1.48M | 0.02% | 640 |
|
|
2020
Q1 | $1.66M | Sell |
28,557
-53,844
| -65% | -$4.37M | 0.1% | 236 |
|
|
2019
Q4 | $7.62M | Buy |
82,401
+72,926
| +770% | +$6.41M | 0.19% | 139 |
|
|
2019
Q3 | $856K | Buy |
+9,475
| New | +$1.08M | 0.03% | 504 |
|
|
2018
Q4 | – | Sell |
-19,100
| Closed | -$1.51M | – | 1117 |
|
|
2018
Q3 | $1.51M | Buy |
+19,100
| New | +$1.25M | 0.07% | 343 |
|
|
2017
Q2 | – | Sell |
-26,119
| Closed | -$616K | – | 653 |
|
|
2017
Q1 | $616K | Buy |
+26,119
| New | +$518K | 0.06% | 333 |
|
|
2016
Q4 | – | Sell |
-69,234
| Closed | -$1.29M | – | 578 |
|
|
2016
Q3 | $1.29M | Buy |
+69,234
| New | +$1.22M | 0.22% | 130 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Schonfeld Strategic Advisors's EXAS Position: Q1 2026 in Review
Schonfeld Strategic Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 592,847 shares — an estimated $60.2M sold.
Schonfeld Strategic Advisors first reported a position in EXAS in Q3 2016 and held it in 18 quarters. The position peaked at $60.2M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Schonfeld Strategic Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 592,847 Exact Sciences shares in Q1 2026, an estimated $60.2M.
- Schonfeld Strategic Advisors first reported a position in Exact Sciences in Q3 2016 and held it in 18 quarters.
- Schonfeld Strategic Advisors's Exact Sciences position peaked at $60.2M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.